Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy

Ophthalmic Research

Volumn 47, Issue 1, 2012, Pages 7-12

  Citirik, Mehmet ^a,c   Kabatas, Emrah Utku ^a   Batman, Cosar ^a   Akin, Kadir Okhan ^b   Kabatas, Naciye ^a  

^a SB Ankara Ulucanlar Eye Education and Research Hospital   (Turkey)

^b Department of Cardiology   (Turkey)

^c NONE   (Turkey)

Author keywords

Proliferative diabetic retinopathy; Proliferative vitreoretinopathy; Retinal detachment; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LENS LUXATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 79959236964     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000324200     Document Type: Article

References (25)

1. Dor Y, Porat R, Keshet E: Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol 2001; 280: 1367-1374.
2. Grosskreutz CL, Anand-Apte B, Duplaa C, et al: Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 1999; 58: 128-136. (Pubitemid 29419938)
3. Aiello LP, Northrup JM, Keyt BA, et al: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113: 1538-1544.
4. Miller JW, Adamis AP, Shima DT, et al: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574-584. (Pubitemid 24285965)
5. Adamis AP, Miller JW, Bernal MT, et al: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445-450. (Pubitemid 24307211)
6. Benjamin LE: Glucose, VEGF-A and diabetic complications. Am J Pathol 2001; 158: 1181-1184.
7. The Retina Society Terminology Committee: An updated classification of retinal detachment with proliferation vitreoretinopathy. Am J Ophthalmol 1991; 112: 159.
8. Caldwell RB, Bartoli M, Behzadian MA, et al: Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2003; 19: 442-455. (Pubitemid 37536961)
9. Diabetic Retinopathy Study Report No. 3: four risk factors for severe visual loss in diabetic retinopathy. Arch Ophthalmol 1979; 97: 658.
10. Amin RH, Frank RN, Kennedy A, et al: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 36-47. (Pubitemid 27051522)
11. Duh EJ, Yang HS, Haller JA, et al: Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 2004; 137: 668-674. (Pubitemid 38446681)
12. Stalmans I, Ng YS, Rohan R, et al: Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109: 327-336. (Pubitemid 34141806)
13. Martin G, Schlunck G, Hansen LL, et al: Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 2004; 242: 321-326. (Pubitemid 38647606)
14. Javerzat S, Auguste P, Bikfalvi A: The role of fibroblast growth factors in vascular development. Trends Mol Med 2002; 8: 483-489.
15. Glaser BM, Cardin A, Biscoe B: Proliferative vitreoretinopathy: the mechanism of development of vitreoretinal traction. Ophthalmology 1987; 94: 327-332. (Pubitemid 17056017)
16. Dieudonné SC, La Heij EC, Diederen RMH, et al: Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res 2007; 39: 148-154. (Pubitemid 46975980)
17. Nicholson BP, Schachat AP: A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010; 248: 915-930.
18. Diabetic Retinopathy Clinical Research Network: A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007; 114: 1860-1867.
19. Ishizaki E, Takai S, Ueki M, et al: Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy. Am J Ophthalmol 2006; 141: 129-134.
20. Watanabe D, Suzuma K, Suzuma I, et al: Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2005; 139: 476-481. (Pubitemid 40379074)
21. Ogata N, Nishikawa M, Nishimura T, et al: Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002; 134: 348-353.
22. Armstrong D, Augustin AJ, Spengler R, et al: Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998; 212: 410-414. (Pubitemid 28446600)
23. Sydorova M, Lee MS: Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Ophthalmic Res 2005; 37: 188-190. (Pubitemid 41404758)
24. Zittermann SI, Issekutz AC: Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 2006; 80: 247-257. (Pubitemid 44835498)
25. Salcedo R, Wasserman K, Young HA, et al: Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999; 154: 1125-1135. (Pubitemid 29169747)